EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 43 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $150,000 | -29.6% | 18,450 | -17.0% | 0.01% | -30.0% |
Q2 2020 | $213,000 | +100.9% | 22,226 | +42.5% | 0.02% | +53.8% |
Q1 2020 | $106,000 | -38.7% | 15,592 | +34.5% | 0.01% | -13.3% |
Q4 2019 | $173,000 | +44.2% | 11,592 | -1.3% | 0.02% | +25.0% |
Q3 2019 | $120,000 | -7.7% | 11,742 | -4.5% | 0.01% | -7.7% |
Q2 2019 | $130,000 | -27.4% | 12,292 | -3.9% | 0.01% | -31.6% |
Q1 2019 | $179,000 | -6.3% | 12,792 | -33.9% | 0.02% | -24.0% |
Q1 2018 | $191,000 | +67.5% | 19,350 | +87.0% | 0.02% | +66.7% |
Q3 2017 | $114,000 | – | 10,350 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |